Central Patient Monitoring Systems Market Is Expected to Play a Vital Role amidst the COVID-19 Pandemic

Central patient monitoring system is a full-featured system that provides comprehensive patient monitoring and review. Though there are many types of patient monitoring systems (such as continuous, real-time, portable, wireless, etc.) they are sorted into two broad categories, such as remote patient monitoring systems and bedside patient monitoring systems. The objective of the patient monitoring is to have a quantitative assessment of the important physiological variables of the patients during critical periods of their biological functions. The growing need for continuous monitoring has led to increased demand for patient monitoring, especially in hospitals with more than 500 beds.

For example, in February 2021, Royal Philips launched the Philips Medical Tablet, a portable monitoring kit designed to help clinicians remotely monitor larger patient populations during emergency healthcare situations, such as the COVID-19 pandemic. This in turn is expected to accelerate the growth of the central patient monitoring systems market. In the recent past, the emergence of COVID-19 has also increased the demand for remote patient monitoring systems due to a large number of patients in hospitals or COVID centers. Remote patient monitoring allows continuous monitoring of patients from a distance, including those who are at homes or in a remote medical facility, help reduce healthcare costs and increase access to primary care.

Growth of the central patient monitoring systems market, in North America, can be attributed to the increasing prevalence of chronic diseases and increasing demand for both portable and wireless systems in this region. For example, in August 2020, Stasis Labs announced the launch of its mobile-connected remote patient monitoring platform for hospital and outpatient in the United States. The Stasis system is made up of a smart device, traditional vital sign sensors, a bedside monitor, and supporting cloud platform. The aforementioned factors are particularly responsible for regional growth, especially in the U.S.

Remote monitoring systems serve with improved chronic disease management, including early warning signs and progress tracker, and thus expected to witness an increased demand, around the world, in the coming years. Every year, chronic conditions account for around 90% of the healthcare costs. Worldwide, diabetes caused around US$ 760 billion in health expenditure in 2019. Central patient monitoring systems help reduce healthcare costs, and thus, there is an increasing demand for them. This in turn is also expected to augment the growth of the central patient monitoring systems market, worldwide.